Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Type 2 Diabetes

University of Alabama at Birmingham Observational Study: Metformin Use Leads to Three-Fold Reduction of COVID-19 Death in Patients with Type 2 Diabetes

In a National Institutes of Health (NIH) supported observational study, the University of Alabama at Birmingham (UAB) revealed that patients […]

University of Alabama at Birmingham Observational Study Metformin Use Leads to Three-Fold Reduction of COVID-19 Death in Patients with Type 2 Diabetes
1 month ago
Share

University of Florida Secures $2.3m for First of its Kind in U.S. Investigating Fatty Liver in Type 2 Diabetics

The University of Florida won a $2.3 million grant in its quest to investigate liver scarring and inflammation triggered by […]

University of Florida Secures $2.3m for First of its Kind in U.S. Investigating Fatty Liver in Type 2 Diabetics
2 months ago
Share

University of Tennessee Secures $1.98m to Pursue Possibly Breakthrough Protein Receptor to Address Type 2 Diabetes

University of Tennessee (UT) Health Science Center Memphis investigators secured $2 million to pursue their potentially breakthrough diabetes research. The […]

University of Tennessee Secures $1.98m to Pursue Possibly Breakthrough Protein Receptor to Address Type 2 Diabetes
1 year ago
Share

Clinical Research as a Care Option in Sacramento CA as Patient Turns Life Around

Clinical Trials Research, a clinical investigational site in the Sacramento, CA area recently saved the life of a man on […]

Clinical Research as a Care Option in Sacramento CA as Patient Turns Life Around
1 year ago
Share

Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug

Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. […]

Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug
1 year ago
Share

WellCare Joins Forces with Fitbit to Help Manage Diabetes in Georgia’s Medicaid Population

WellCare of Georgia, a WellCare Health Plans, Inc. company (WCG), recently partnered with Fitbit to improve health and manage diabetes […]

WellCare Joins Forces with Fitbit to Help Manage Diabetes in Georgia’s Medicaid Population
1 year ago
Share

Type 2 Diabetic Crisis in India and Treatment Options: Caveat Emptor

With growth in India’s economy and middle class has come new diseases heretofore not that pervasive in India, such as […]

1 year ago
Share

Brigham and Women’s Hospital & Boehringer Ingelheim Share Interim Analysis of EMPRISE Real-World Study

Industry Sponsor-funded real-world study called EMPagliflozin comparative effectiveness and SafEty (EMPRISE) reveals that empagliflozin was associated with a decreased risk […]

Brigham and Women’s Hospital & Boehringer Ingelheim Share Interim Analysis of EMPRISE Real-World Study
1 year ago
Share

University of Kansas and AstraZeneca Team Up to Study Link Between Diabetes & AD

The University of Kansas Alzheimer’s Disease Center (KU ADC) and AstraZeneca have partnered to conduct a study to attempt to […]

Teva’s Fremanezumab Demonstrates Early Onset of Efficacy for the Preventive Treatment of Chronic Migraine
1 year ago
Share

Virta Health Pilot Study Reveals it can Possibly Turn Around Type 2 Diabetes in Veterans via Nutritional Ketosis

A Virta Health pilot study reveals that 84% of veteran patients on the Virta Treatment for 90 days achieved glycemic […]

Virta Health Pilot Study Reveals it can Possibly Turn Around Type 2 Diabetes in Veterans via Nutritional Ketosis
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.